Bill Ritter spoke with doctors at Columbia about Alzheimer's disease and their groundbreaking research.

Alzheimer's disease is a devastating neurodegenerative disorder affecting millions of people worldwide. Scientists have long ...

New studies point to the power of testing for and treating tau, a protein that builds up in Alzheimer’s disease, instead of just amyloid.

The FDA is allowing MMI to enroll more patients in a feasibility trial studying use of the Symani robot for microsurgery to ...

Rather than target amyloid plaques, the potential new treatment aims to restore immune functions that naturally decline with age.

When looking at geographies, the US accounts for approximately 32.7% of total activity, making it the clear leader in the ...

"SuperAgers" keep razor-sharp memories past 80, but a new study shows this is not just down to good genes.

Summary: Researchers identified a novel form of neuropathology in Alzheimer’s disease: mitochondrial plaques. The study demonstrates that these intracellular, mitochondrially localized plaques emerge ...

The lead researcher told Newsweek that an entire American population has largely been overlooked in brain health studies.

With so many unknowns, Biogen is carefully eyeing its next-gen Alzheimer’s treatment diranersen as a high-risk, high-reward ...

Researchers have uncovered a possible biological pathway connecting obesity to Alzheimer’s disease. Obesity appears to raise levels of certain fat molecules that can travel to the brain, disrupt its ...

Danny Glover and his support network share intimate details about his journey with Alzheimer’s in this week’s issue of PEOPLE ...